Bicara Therapeutics BCAX Current State And Local Tax Expense Benefit
Current State And Local Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CurrentStateAndLocalTaxExpenseBenefit.
The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's current state and local tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's current state and local tax expense benefit?
- Bicara Therapeutics (BCAX) reported current state and local tax expense benefit of $54.25K in Q4 2025.
- How has Bicara Therapeutics's current state and local tax expense benefit changed year-over-year?
- Bicara Therapeutics's current state and local tax expense benefit increased by 16.0% year-over-year, from $46.75K to $54.25K.
- What does current state and local tax expense benefit mean?
- This metric captures the current income tax expense or benefit related to state and local jurisdictions. It reflects the tax burden or relief imposed by regional authorities on the company's operations. Analyzing this helps in assessing the geographic tax impact on the company's bottom line.